Search results
Added:
1 year ago
AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.Dr Walid Saliba (Cleveland Clinic, OH, US) joins us onsite at AF Symposium 25 to discuss the findings from the concomitant and…
View more
Added:
1 week ago
HRS Congress 2026 — Prof Ulrich Schotten (Maastricht University, Maastricht, NL) joins us to discuss new findings from the NOAH-AFNET 6 trial examining the distribution of atrial fibrillation burden, its relationship to clinical outcomes, and the effectiveness and safety of anticoagulation based on device reports.NOAH-AFNET 6 (Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial…
View more
AHA 25: The OCEAN Trial
Added:
6 months ago
Video
Added:
2 years ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from…
View more
Added:
1 month ago
EHRA 2026 — Prof Pier Lambiase (University College London, UK) joins us to examine the evolving landscape of VT mapping, exploring how advances in identifying arrhythmia drivers and delineating conduction channels are reshaping ablation strategy and outcomes in complex ventricular arrhythmia.From the limitations of conventional substrate mapping to the growing role of high-density mapping systems…
View more
Added:
1 year ago
ESC Congress 2024 — Chair, Prof Isabelle C Van Gelder (University of Groningen, NL) joins us to discuss key highlights from the ESC Atrial Fibrillation 2024 guidelines.The new guidelines centre on shared and equal care, patient empowerment, comorbidities and risk factor management, and evidence-based management and re-evaluation. The new AF-CARE pathway integrates comorbidity management,…
View more
Added:
1 year ago
A new policy statement released by HRS underscores the importance of continual training and education for electrophysiologists performing catheter ablation of atrial fibrillation (AF).In this short interview, Dr Kenneth Ellenbogen (VCU School of Medicine, US) discusses the key recommendations within this policy statement to ensure a strong electrophysiology base and skillset to achieve the best…
View more
Added:
1 year ago
EHRA 2025 - We are joined onsite at EHRA Congress 2025 by Prof Pier Lambiase to discuss the latest developments in ventricular tachycardia substrate identification from the EHRA Ablation Summit 2025.Interview Questions:What are the key challenges or limitations that still exist in accurately identifying VT substrates?What are the most significant recent advancements in techniques or technologies…
View more
Added:
1 year ago
ESC Congress 2024 — Dr Dipak Kotecha (University of Birmingham, UK) joins us onsite in London to discuss key highlights from the ESC Atrial Fibrillation 2024 guidelines.Interview Questions:1. What is the prevalence of AF and the unmet needs of patients in 2024?2. What's new in the guidelines?3. What are some areas for improvement?4. What are some of the challenges and opportunities with the…
View more
LB-NICM: New Approach
Added:
1 year ago
Review Article